Science Oriented
Overview

Establishedin 2005, XP Biomed Ltd. started as a distribution and marketing company inShanghai, China. Over the years, we have promotedsmall & big biotech companies from around the world, such as MolecularDevice, Beckman Coulter, AB Sciex, Dako, HeMarina, Cell Culture Technology, Chemometec,BiologicalIndustries, etc.

In2014, a GMP compliant joint venture was setup with Israel Biological Industries(BI) in Shanghai,dedicatedto provide cell culture reagents to China market, such as serum, basal medium,buffers, auxiliary reagents and cytogenetic karyotyping medium.

AfterSartorius acquired BI in 2019, XP Biomed started independently with it’sown brand “VivaCell” in our new state of the art GMP compliant, ISO13485certified cleanroom. Besides original product line, we have expanded ourportfolio into animal component free products, and providing Dr.Cell™ technical services (China only), suchas: cellauthentication STR, speciesID, karyotyping, exosome NTA etc. Our products and services has been cited inmore than 300+ articles in SCI journals. Testifying our commitment to ourproduct quality and attitude towards our customers.

XPBiomed aims at combining latest cell culture technology, such as: 3D organoid,exosome, and cell therapy to enhance the progress of cell culture applicationwith Science Oriented in mind, we aim to take the “ART” out of cell culture andis proud to help our academic and industrial customers to solve their questionsand needs in cell culture practice.


  • Focusing on the field of cell culture

  • Sold in 18 countries Meets & excel global standards

  • High standard production base

  • Number of customers served

  • Assist scientific research and improve the quality of life

  • To establish as a leader in the cell culture industry, consistently delivering high-quality, innovative products. We aim to be a globally-minded enterprise that drives the advancement of "Intelligent Manufacturing in China."

  • Begin with science Be loyal to science

  • 2005

    Establishment of Shanghai XP

  • 2012

    Launch of the VivaCell brand

  • 2014

    Formation of a joint venture with Israel's Biological Industries (BI), leading to the creation of BI(Shanghai) Biotechnology Co., Ltd., specializing in the production of cell culture-related reagents.

  • 2015

    Obtained medical device production license filing and registration certificates for eight Class I medical device products

  • 2016

    Certification as a High-Tech Enterprise in Shanghai

    Achieved ISO9001 and ISO13485 certifications by TÜV Rheinland and SÜD

  • 2019

    Expansion of exports to multiple countries across Europe, the Middle East, and Southeast Asia

  • 2020

    XP fully acquired the Chinese joint venture with Israel‘s BI, and the factory was renamed Shanghai Dr. Cell Biotechnology Co., Ltd.

  • 2024

    Relocation to the Oriental Beauty in Fengxian, Shanghai, with ongoing project developments

  • 2025

    Waiting for the update...

Online consultation
WeChat official account
Online consultation
Contact Us